Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUT014 for Radiation-Induced Dermatitis in Breast Cancer
NCT04261387Phase 2Completed
- Sponsor
- Lutris Pharma
- Start
- Jan 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LUT014 in radiation dermatitis, sponsored by Lutris Pharma. Started Jan 2021; status: completed.
02
Drugs
LUT014
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT04261387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04261387.